Evidence for the Involvement of Descending Pain-Inhibitory Mechanisms in the Antinociceptive Effect of Hecogenin Acetate
| Autor: | Kelly Barbosa Gama, Ângelo R. Antoniolli, Wagno Alcântara de Santana, Lucindo José Quintans-Júnior, Jullyana S.S. Quintans, Cristiane Flora Villarreal, Alexsandro Branco, Milena Botelho Pereira Soares |
|---|---|
| Rok vydání: | 2013 |
| Předmět: |
Male
medicine.drug_class Receptors Opioid mu Pain Pharmaceutical Science (+)-Naloxone Pharmacology Periaqueductal gray Analytical Chemistry Mice Agave KATP Channels Opioid receptor Glyburide Drug Discovery medicine Animals Periaqueductal Gray Spiro Compounds Analgesics Molecular Structure Chemistry Receptors Opioid kappa Organic Chemistry Antagonist Receptor antagonist Naltrexone Plant Leaves Nociception Complementary and alternative medicine Mechanism of action Molecular Medicine Steroids medicine.symptom Tail flick test |
| Zdroj: | Journal of Natural Products. 76:559-563 |
| ISSN: | 1520-6025 0163-3864 |
| DOI: | 10.1021/np3007342 |
| Popis: | Hecogenin is a sapogenin present in the leaves of species from the Agave genus, with a wide spectrum of reported pharmacological activities. The present study was undertaken to evaluate whether hecogenin acetate (1) has antinociceptive properties and to determine its mechanism of action. The nociceptive threshold was evaluated using the tail flick test in mice. Mice motor performance was evaluated in a Rotarod test. By using Fos expression as a marker of neural activation, the involvement of the periaqueductal gray in 1-induced antinociception was evaluated. Intraperitoneal administration of 1 (5-40 mg/kg) produced a dose-dependent increase in the tail flick latency time compared to vehicle-treated group (p0.01). Mice treated with 1 (40 mg/kg) did not show motor performance alterations. The antinociception of 1 (40 mg/kg) was prevented by naloxone (nonselective opioid receptor antagonist; 5 mg/kg), CTOP (μ-opioid receptor antagonist; 1 mg/kg), nor-BNI (κ-opioid receptor antagonist; 0.5 mg/kg), naltrindole (δ-opioid receptor antagonist; 3 mg/kg), or glibenclamide (ATP-sensitive K(+) channel blocker; 2 mg/kg). Systemic administration of 1 (5-40 mg/kg) increased the number of Fos positive cells in the periaqueductal gray. The present study has demonstrated for the first time that 1 produces consistent antinociception mediated by opioid receptors and endogenous analgesic mechanisms. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|